Home Biosimilar Antibodies Immunology & Inflammation Interleukins inhibitor Ustekinumab (anti-IL-12/IL-23) For research use only.
Not for use in humans.

Ustekinumab (anti-IL-12/IL-23)

Synonyms: CNTO 1275

Ustekinumab (CNTO 1275) is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody used to treat psoriasis. MW=145.6 kDa.

Ustekinumab (anti-IL-12/IL-23)

Click to purchase the isotype control of Ustekinumab (anti-IL-12/IL-23)

Purity & Quality Control

Batch: A202401 Purity: 99.12% Protein concentration: 5.00mg/ml Endotoxin Level: ≤1 EU/mg
99.12

Choose Selective Interleukins Inhibitors

Name Citation IL-6 IL-1 IL-8 IL-12 IL-10 IL-13 IL-2 Others
SKF-86002 0
JTE-607 Dihydrochloride 0 TNF-alpha
A-740003 2 rat P2X7 receptor,human P2X7 receptor
Apilimod mesylate 3 PIKfyve
MD2-TLR4-IN-1 0 TLR4,TNF-α
Danirixin (GSK1325756) 2 CXCR2
Resatorvid (TAK-242) 50 TLR4,NO,TNF-α
Apilimod 14 PIKfyve
LMT-28
Atractylodin NAAA
Triolein ROS,MMP-1
Ac-YVAD-cmk
Diethyl phosphate
RCM-1 STAT6,FOXM1,β-catenin
Stylopine COX-2,TNF-α,NO
Myrislignan NF-κB,COX-2,iNOS
NE 52-QQ57 iNOS,TNF-α,PGE2
PKR-IN-C16 PKR
Falcarindiol STAT,ERK,JNK
Gardenoside P2X7 Receptor,P2X3 receptor,NF-κB
T-5224 c-Jun,c-Fos/AP-1,Adamts-5
IQ 3 TNF-α,JNK3,JNK1
Isuzinaxib (APX-115 free base) TNFα,MCP-1/CCL2,NOX2
AUDA p38,Smad3,TGF-β
SAR-20347 IFN-α,TYK2,JAK1
SU 5201
Madecassic acid TNF-α,COX-2,iNOS
Homoplantaginin NF-κB,IKKβ,TNF-α
2',5'-Dihydroxyacetophenone NF-κB,ERK1/2,iNOS
Forsythoside B NF-κB,TNF-alpha,IκB
Mulberroside A NF-κB,Caspase-1,NALP3
Chelidonic acid glutamate decarboxylase,Caspase-1,NF-κB
4-Methylesculetin MPO
Muscone TNF-α,NLRP3 inflammasome,NF-κB
Ossirene (AS101)
Methylthiouracil ERK1/2,NF-κB,TNF-α
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Ustekinumab (CNTO 1275) is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody used to treat psoriasis. MW=145.6 kDa.
In Vitro
In vitro

The addition of Ustekinumab (UST) significantly inhibits T follicular helper (TFH) cell differentiation in vitro.[1]
Cell Research:

Objective: TFH cell differentiation assay
Cells: naïve CD4+ T cells, T follicular helper (TFH) cells, PBMCs
Concentrations: 100 ng/mL
Incubation Time: 24 h
Method: The TFH cell differentiation assay is performed with freshly isolated PBMCs from healthy donors (n = 16). Naïve CD4+ T cells are isolated by using the human Naïve CD4+ T Cell Isolation Kit II. A total of 500,000 naïve CD4+ T cells are cultured in complete medium in the presence of 12.5 μL/mL anti-CD3/CD28 in a flat-bottom 48 well plate. After 24 hours of culture, cytokines are added and cells are incubated for additional 2.5 days. A total of 5 ng/mL IL-12 + 5 ng/mL TGFβ with and without 100 ng/mL UST and 100 ng/mL UST alone are used.
Reference: https://pubmed.ncbi.nlm.nih.gov/32679193

Ustekinumab can apply to humanized mice, peripheral blood and other related assays (Only for Reference)
In Vivo
In vivo

Ustekinumab is generated via recombinant human IL-12 immunization of human Ig (hu-Ig) transgenic mice. Ustekinumab binds to the p40 subunit common to IL-12 and IL-23 and prevents their interaction with the IL-12 receptor β1 subunit of the IL-12 and IL-23 receptor complexes.[2]

Product Details

CAS No. 815610-63-0
Isotype Human IgG1
Source Human
Formulation PBS, PH7.2
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ustekinumab (anti-IL-12/IL-23) | Ustekinumab (anti-IL-12/IL-23) supplier | purchase Ustekinumab (anti-IL-12/IL-23) | Ustekinumab (anti-IL-12/IL-23) cost | Ustekinumab (anti-IL-12/IL-23) manufacturer | order Ustekinumab (anti-IL-12/IL-23) | Ustekinumab (anti-IL-12/IL-23) distributor